INmune Bio’s XPro1595 Prevents Brain-Injury-Induced Alzheimer's Pathology, Memory Loss, and Pain in New Peer-Reviewed Preclinical Study

Go back to INmune Bio’s XPro1595 Prevents Brain-Injury-Induced Alzheimer's Pathology, Memory Loss, and Pain in New Peer-Reviewed Preclinical Study
(NASDAQ: INMB) Delayed: 2.54 +0.03 (1.20%)
Previous Close $2.51    52 Week High
Open $2.55    52 Week Low
Day High $2.58    P/E N/A 
Day Low $2.47    EPS
Volume 134,197       

(NASDAQ: INMB) Delayed: 2.54 +0.03 (1.20%)
Previous Close $2.51    52 Week High
Open $2.55    52 Week Low
Day High $2.58    P/E N/A 
Day Low $2.47    EPS
Volume 134,197